サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1660930

中国伝統医学（TCM）の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Traditional Chinese Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 193 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
中国伝統医学（TCM）の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年02月20日
発行: Persistence Market Research
ページ情報: 英文 193 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の中国伝統医学（TCM）の市場規模は、2025年に333億米ドルになるとみられ、2025年～2032年の予測期間に5.3%のCAGRで拡大し、2032年には478億米ドルに達すると予測されています。

中国伝統医学（TCM）には、漢方薬、鍼治療、カッピング療法、太極拳など、さまざまな治療法が含まれ、何世紀にもわたってさまざまな健康状態の治療に用いられてきました。この市場には、天然ハーブ、植物性抽出物、伝統的な治療技術に由来する製剤が含まれます。TCMは病院、診療所、ウェルネスセンター、在宅医療の現場で広く採用されており、疼痛管理、慢性疾患治療、消化器疾患、免疫システム強化などに応用されています。市場の成長には、自然でホリスティックな治療法に対する消費者の嗜好の高まり、TCMの主流ヘルスケアへの統合、現代医学的症状への有効性に関する研究の拡大が寄与しています。

世界の中国伝統医学市場は、代替・補完医療の人気の高まり、ハーブや自然療法に対する消費者の意識の高まり、統合ヘルスケア環境におけるTCMの受け入れ拡大など、いくつかの重要な要因によって推進されています。中国、日本、韓国などの各国政府は、政策支援や研究資金援助を通じてTCMを積極的に推進し、市場拡大を促進しています。さらに、ナノテクノロジーを利用したハーブの抽出やデジタルTCM診断ツールなど、TCM処方における技術の進歩は、治療効果と利用しやすさを高めています。糖尿病、高血圧、慢性疼痛などの生活習慣病が増加していることも、TCMをベースとした治療への需要を促進しています。

中国伝統医学（TCM）市場は、研究開発への投資の増加、個別化医療の進歩、ウェルネス・ツーリズムの動向の高まりにより、大きな成長機会をもたらしています。TCMと、AIを活用した診断や遠隔医療相談といった最新のデジタルヘルス技術との統合は、アクセシビリティと患者の関与を高めています。さらに、天然有機治療への需要が高まっている北米と欧州における輸出機会の拡大が、市場参入企業に新たな道を開いています。TCMメーカー、製薬会社、研究機関の戦略的提携は、技術革新と世界市場への浸透をさらに促進することができます。

当レポートでは、世界の中国伝統医学（TCM）市場について調査し、製品別、疾患別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 重要成功要因

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 動向

第6章 COVID-19危機- 影響評価

第7章 世界市場の需要（価値または規模、10億米ドル）分析、2019年～2032年

  • 過去の市場規模（10億米ドル）分析、2019年～2024年
  • 現在および将来の市場規模（10億米ドル）予測、2025年～2032年

第8章 世界市場分析、製品別、2019年～2032年

  • 過去の市場規模（10億米ドル）分析、製品別、2019年～2024年
  • 現在および将来の市場規模（10億米ドル）分析と予測、製品別、2025年～2032年
  • 製品別市場の魅力分析

第9章 世界市場分析、疾病別、2019年～2032年

  • 過去の市場規模（10億米ドル）分析、疾病別、2019年～2024年
  • 現在および将来の市場規模（10億米ドル）分析と予測、疾病別、2025年～2032年
  • 疾病別市場の魅力分析

第10章 世界市場分析、地域別、2019年～2032年

  • 過去の市場規模（10億米ドル）分析、地域別、2019年～2024年
  • 現在および将来の市場規模（10億米ドル）分析と予測、地域別、2025年～2032年
  • 地域別市場の魅力分析

第11章 北米市場分析、2019年～2032年

第12章 ラテンアメリカ市場分析、2019年～2032年

第13章 欧州市場分析、2019年～2032年

第14章 南アジア市場分析、2019年～2032年

第15章 東アジア市場分析、2019年～2032年

第16章 オセアニア市場分析、2019年～2032年

第17章 中東・アフリカ市場分析、2019年～2032年

第18章 市場構造分析

第19章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • Tongrentang
    • Zhongxin Pharmaceuticals
    • Tianjin Tasly Group
    • Yuannan Baiyao
    • Solstice Medicine Company, Inc.
    • Shanghai Sundise Traditional Chinese Medicine Co., Ltd
    • China Chinese Medicine Holding Co., Ltd.
    • Hunan goldliloo pharmaceutical Co., Ltd
    • Wanbang Pharma Group Corp.
    • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
    • Pfizer Inc.
    • Eli Lilly and Company
    • Novartis AG
    • GlaxoSmithKline PLC
    • Mallinckrodt Pharmaceuticals
    • Hisamitsu Pharmaceutical Co., Inc.

第20章 使用される仮定と頭字語

第21章 調査手法

目次
Product Code: PMRREP16219

Persistence Market Research has recently released a comprehensive report on the worldwide market for Traditional Chinese Medicine (TCM). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Traditional Chinese Medicine market from 2025 to 2032.

Key Insights:

  • Traditional Chinese Medicine Market Size (2025E): USD 33.3 Billion
  • Projected Market Value (2032F): USD 47.8 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.3%

Traditional Chinese Medicine Market - Report Scope:

Traditional Chinese Medicine (TCM) encompasses a range of therapies, including herbal medicine, acupuncture, cupping therapy, and Tai Chi, used for centuries to treat various health conditions. The market includes formulations derived from natural herbs, plant-based extracts, and traditional healing techniques. TCM is widely adopted in hospitals, clinics, wellness centers, and homecare settings, with applications in pain management, chronic disease treatment, digestive disorders, and immune system enhancement. The market's growth is fueled by increasing consumer preference for natural and holistic treatments, the integration of TCM into mainstream healthcare, and expanding research into its efficacy for modern medical conditions.

Market Growth Drivers:

The global Traditional Chinese Medicine market is propelled by several key factors, including the rising popularity of alternative and complementary medicine, increased consumer awareness of herbal and natural treatments, and growing acceptance of TCM in integrative healthcare settings. Governments in countries like China, Japan, and South Korea actively promote TCM through policy support and research funding, fostering market expansion. Additionally, technological advancements in TCM formulation, such as nanotechnology-based herbal extractions and digital TCM diagnostic tools, enhance treatment effectiveness and accessibility. The increasing prevalence of lifestyle-related diseases, such as diabetes, hypertension, and chronic pain, further drives demand for TCM-based therapies.

Market Restraints:

Despite promising growth prospects, the Traditional Chinese Medicine market faces challenges related to regulatory compliance, standardization, and skepticism from the scientific community. The lack of universal standards in herbal medicine formulations and variations in TCM practices across regions create barriers to market expansion. Additionally, concerns over the quality and authenticity of herbal ingredients, along with potential side effects and drug interactions, pose challenges for consumer adoption. Limited clinical research validating the effectiveness of TCM treatments in comparison to conventional medicine also hinders broader acceptance. Addressing these challenges requires rigorous research, standardized quality control, and stronger regulatory frameworks to ensure the safety and efficacy of TCM products.

Market Opportunities:

The Traditional Chinese Medicine market presents significant growth opportunities driven by increasing investment in research and development, advancements in personalized medicine, and the rising trend of wellness tourism. The integration of TCM with modern digital health technologies, such as AI-driven diagnostics and telemedicine consultations, enhances accessibility and patient engagement. Furthermore, expanding export opportunities in North America and Europe, where demand for natural and organic treatments is rising, creates new avenues for market players. Strategic collaborations between TCM manufacturers, pharmaceutical companies, and research institutions can further drive innovation and global market penetration.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Traditional Chinese Medicine market globally?
  • Which TCM therapies and applications are gaining the most traction in different healthcare settings?
  • How are technological advancements shaping the future of the TCM market?
  • Who are the key players influencing the TCM market, and what strategies are they adopting for market expansion?
  • What are the emerging trends and growth opportunities in the global Traditional Chinese Medicine market?

Competitive Intelligence and Business Strategy:

Leading players in the global Traditional Chinese Medicine market, including Tong Ren Tang, Yunnan Baiyao, and Beijing Tongrentang Co., Ltd., focus on product innovation, quality standardization, and international market expansion. These companies invest in advanced herbal extraction technologies, conduct clinical research on TCM efficacy, and engage in strategic partnerships with pharmaceutical firms to enhance credibility. Collaborations with hospitals, wellness centers, and e-commerce platforms also facilitate wider market penetration. Additionally, initiatives promoting sustainable and organic sourcing of medicinal herbs ensure long-term market sustainability and consumer trust.

Key Companies Profiled:

  • Tong Ren Tang
  • Yunnan Baiyao
  • Beijing Tongrentang Co., Ltd.
  • Tasly Pharmaceutical Group Co., Ltd.
  • China Shineway Pharmaceutical Group
  • Guangzhou Baiyunshan Pharmaceutical Holdings
  • Zhejiang Chinese Medical University Pharmaceutical
  • Jiangzhong Pharmaceutical Co., Ltd.

Key Segments Covered in Traditional Chinese Medicine Industry Research

Product:

  • Traditional Chinese Medicine (TCM)
  • Non-Traditional Chinese Medicine (Non-TCM)

Disease:

  • Autism Spectrum Disorder (ASD)
  • Attention Deficit Hyperactivity Disorder (ADHD)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Herbal Medicine Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Adoption Of TCM
    • 5.2.2. Massive Infrastructure Planning for Global Manufacturing
    • 5.2.3. Favourable Regulatory and Reimbursement Scenario
    • 5.2.4. Increasing Research and Development
    • 5.2.5. Growth of Top Companies
    • 5.2.6. Mergers and Acquisitions
    • 5.2.7. Increasing Incidence of Lifestyle Diseases
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Disease
    • 6.1.3. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019 - 2032

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019 - 2024
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2025 - 2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis , 2019 - 2032

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019 - 2024
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2025 - 2032
    • 8.3.1. Traditional Chinese Medicine (TCM)
      • 8.3.1.1. Autism Spectrum Disorder (ASD)
      • 8.3.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
    • 8.3.2. Non-Traditional Chinese Medicine (Non-TCM)
      • 8.3.2.1. Autism Spectrum Disorder (ASD)
      • 8.3.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019 - 2032, by Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Disease, 2019 - 2024
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Disease, 2025 - 2032
    • 9.3.1. Autism Spectrum Disorder (ASD)
    • 9.3.2. Attention Deficit Hyperactivity Disorder (ADHD)
  • 9.4. Market Attractiveness Analysis By Disease

10. Global Market Analysis 2019 - 2032, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019 - 2024
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2025 - 2032
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (Middle East and Africa (MEA))
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By Disease
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By Disease
  • 11.5. Country Level Analysis & Forecast
    • 11.5.1. U.S. Market Analysis
      • 11.5.1.1. Introduction
      • 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.1.2.1. By Product
        • 11.5.1.2.2. By Disease
    • 11.5.2. Canada Market Analysis
      • 11.5.2.1. Introduction
      • 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.2.2.1. By Product
        • 11.5.2.2.2. By Disease
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Disease
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Disease
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. Brazil Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Product
        • 12.5.1.2.2. By Disease
    • 12.5.2. Mexico Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Product
        • 12.5.2.2.2. By Disease
    • 12.5.3. Argentina Market Analysis
      • 12.5.3.1. Introduction
      • 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.3.2.1. By Product
        • 12.5.3.2.2. By Disease
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2025 - 2032
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. BENELUX
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By Disease
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Disease
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Germany Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Disease
    • 13.5.2. France Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Disease
    • 13.5.3. Italy Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Product
        • 13.5.3.2.2. By Disease
    • 13.5.4. U.K. Market Analysis
      • 13.5.4.1. Introduction
      • 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.4.2.1. By Product
        • 13.5.4.2.2. By Disease
    • 13.5.5. Spain Market Analysis
      • 13.5.5.1. Introduction
      • 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.5.2.1. By Product
        • 13.5.5.2.2. By Disease
    • 13.5.6. Russia Market Analysis
      • 13.5.6.1. Introduction
      • 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.6.2.1. By Product
        • 13.5.6.2.2. By Disease
    • 13.5.7. Nordic Countries Market Analysis
      • 13.5.7.1. Introduction
      • 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.7.2.1. By Product
        • 13.5.7.2.2. By Disease
    • 13.5.8. BENELUX Market Analysis
      • 13.5.8.1. Introduction
      • 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.8.2.1. By Product
        • 13.5.8.2.2. By Disease
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019 - 2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Thailand
      • 14.3.1.3. Indonesia
      • 14.3.1.4. Malaysia
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By Disease
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. India Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Disease
    • 14.5.2. Thailand Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Disease
    • 14.5.3. Indonesia Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Disease
    • 14.5.4. Malaysia Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Product
        • 14.5.4.2.2. By Disease
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Disease
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. China Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Disease
    • 15.5.2. Japan Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Disease
    • 15.5.3. South Korea Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Disease
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019 - 2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By Disease
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Australia Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Disease
    • 16.5.2. New Zealand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Disease
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019 - 2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By Disease
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. GCC Countries Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Disease
    • 17.5.2. Turkiye Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Disease
    • 17.5.3. Northern Africa Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Disease
    • 17.5.4. South Africa Market Analysis
      • 17.5.4.1. Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Product
        • 17.5.4.2.2. By Disease
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Branding and Promotional Strategies
  • 19.3. Key Development Analysis
  • 19.4. Competition Deep Dive
    • 19.4.1. Tongrentang
      • 19.4.1.1. Overview
      • 19.4.1.2. Product Portfolio
      • 19.4.1.3. Key Financials
      • 19.4.1.4. Sales Footprint
      • 19.4.1.5. SWOT Analysis
      • 19.4.1.6. Strategy Overview
        • 19.4.1.6.1. Marketing Strategy
        • 19.4.1.6.2. Product Strategy
        • 19.4.1.6.3. Channel Strategy
    • 19.4.2. Zhongxin Pharmaceuticals
      • 19.4.2.1. Overview
      • 19.4.2.2. Product Portfolio
      • 19.4.2.3. Key Financials
      • 19.4.2.4. Sales Footprint
      • 19.4.2.5. SWOT Analysis
      • 19.4.2.6. Strategy Overview
        • 19.4.2.6.1. Marketing Strategy
        • 19.4.2.6.2. Product Strategy
        • 19.4.2.6.3. Channel Strategy
    • 19.4.3. Tianjin Tasly Group
      • 19.4.3.1. Overview
      • 19.4.3.2. Product Portfolio
      • 19.4.3.3. Key Financials
      • 19.4.3.4. Sales Footprint
      • 19.4.3.5. SWOT Analysis
      • 19.4.3.6. Strategy Overview
        • 19.4.3.6.1. Marketing Strategy
        • 19.4.3.6.2. Product Strategy
        • 19.4.3.6.3. Channel Strategy
    • 19.4.4. Yuannan Baiyao
      • 19.4.4.1. Overview
      • 19.4.4.2. Product Portfolio
      • 19.4.4.3. Key Financials
      • 19.4.4.4. Sales Footprint
      • 19.4.4.5. SWOT Analysis
      • 19.4.4.6. Strategy Overview
        • 19.4.4.6.1. Marketing Strategy
        • 19.4.4.6.2. Product Strategy
        • 19.4.4.6.3. Channel Strategy
    • 19.4.5. Solstice Medicine Company, Inc.
      • 19.4.5.1. Overview
      • 19.4.5.2. Product Portfolio
      • 19.4.5.3. Key Financials
      • 19.4.5.4. Sales Footprint
      • 19.4.5.5. SWOT Analysis
      • 19.4.5.6. Strategy Overview
        • 19.4.5.6.1. Marketing Strategy
        • 19.4.5.6.2. Product Strategy
        • 19.4.5.6.3. Channel Strategy
    • 19.4.6. Shanghai Sundise Traditional Chinese Medicine Co., Ltd
      • 19.4.6.1. Overview
      • 19.4.6.2. Product Portfolio
      • 19.4.6.3. Key Financials
      • 19.4.6.4. Sales Footprint
      • 19.4.6.5. SWOT Analysis
      • 19.4.6.6. Strategy Overview
        • 19.4.6.6.1. Marketing Strategy
        • 19.4.6.6.2. Product Strategy
        • 19.4.6.6.3. Channel Strategy
    • 19.4.7. China Chinese Medicine Holding Co., Ltd.
      • 19.4.7.1. Overview
      • 19.4.7.2. Product Portfolio
      • 19.4.7.3. Key Financials
      • 19.4.7.4. Sales Footprint
      • 19.4.7.5. SWOT Analysis
      • 19.4.7.6. Strategy Overview
        • 19.4.7.6.1. Marketing Strategy
        • 19.4.7.6.2. Product Strategy
        • 19.4.7.6.3. Channel Strategy
    • 19.4.8. Hunan goldliloo pharmaceutical Co., Ltd
      • 19.4.8.1. Overview
      • 19.4.8.2. Product Portfolio
      • 19.4.8.3. Key Financials
      • 19.4.8.4. Sales Footprint
      • 19.4.8.5. SWOT Analysis
      • 19.4.8.6. Strategy Overview
        • 19.4.8.6.1. Marketing Strategy
        • 19.4.8.6.2. Product Strategy
        • 19.4.8.6.3. Channel Strategy
    • 19.4.9. Wanbang Pharma Group Corp.
      • 19.4.9.1. Overview
      • 19.4.9.2. Product Portfolio
      • 19.4.9.3. Key Financials
      • 19.4.9.4. Sales Footprint
      • 19.4.9.5. SWOT Analysis
      • 19.4.9.6. Strategy Overview
        • 19.4.9.6.1. Marketing Strategy
        • 19.4.9.6.2. Product Strategy
        • 19.4.9.6.3. Channel Strategy
    • 19.4.10. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
      • 19.4.10.1. Overview
      • 19.4.10.2. Product Portfolio
      • 19.4.10.3. Key Financials
      • 19.4.10.4. Sales Footprint
      • 19.4.10.5. SWOT Analysis
      • 19.4.10.6. Strategy Overview
        • 19.4.10.6.1. Marketing Strategy
        • 19.4.10.6.2. Product Strategy
        • 19.4.10.6.3. Channel Strategy
    • 19.4.11. Pfizer Inc.
      • 19.4.11.1. Overview
      • 19.4.11.2. Product Portfolio
      • 19.4.11.3. Key Financials
      • 19.4.11.4. Sales Footprint
      • 19.4.11.5. SWOT Analysis
      • 19.4.11.6. Strategy Overview
        • 19.4.11.6.1. Marketing Strategy
        • 19.4.11.6.2. Product Strategy
        • 19.4.11.6.3. Channel Strategy
    • 19.4.12. Eli Lilly and Company
      • 19.4.12.1. Overview
      • 19.4.12.2. Product Portfolio
      • 19.4.12.3. Key Financials
      • 19.4.12.4. Sales Footprint
      • 19.4.12.5. SWOT Analysis
      • 19.4.12.6. Strategy Overview
        • 19.4.12.6.1. Marketing Strategy
        • 19.4.12.6.2. Product Strategy
        • 19.4.12.6.3. Channel Strategy
    • 19.4.13. Novartis AG
      • 19.4.13.1. Overview
      • 19.4.13.2. Product Portfolio
      • 19.4.13.3. Key Financials
      • 19.4.13.4. Sales Footprint
      • 19.4.13.5. SWOT Analysis
      • 19.4.13.6. Strategy Overview
        • 19.4.13.6.1. Marketing Strategy
        • 19.4.13.6.2. Product Strategy
        • 19.4.13.6.3. Channel Strategy
    • 19.4.14. GlaxoSmithKline PLC
      • 19.4.14.1. Overview
      • 19.4.14.2. Product Portfolio
      • 19.4.14.3. Key Financials
      • 19.4.14.4. Sales Footprint
      • 19.4.14.5. SWOT Analysis
      • 19.4.14.6. Strategy Overview
        • 19.4.14.6.1. Marketing Strategy
        • 19.4.14.6.2. Product Strategy
        • 19.4.14.6.3. Channel Strategy
    • 19.4.15. Mallinckrodt Pharmaceuticals
      • 19.4.15.1. Overview
      • 19.4.15.2. Product Portfolio
      • 19.4.15.3. Key Financials
      • 19.4.15.4. Sales Footprint
      • 19.4.15.5. SWOT Analysis
      • 19.4.15.6. Strategy Overview
        • 19.4.15.6.1. Marketing Strategy
        • 19.4.15.6.2. Product Strategy
        • 19.4.15.6.3. Channel Strategy
    • 19.4.16. Hisamitsu Pharmaceutical Co., Inc.
      • 19.4.16.1. Overview
      • 19.4.16.2. Product Portfolio
      • 19.4.16.3. Key Financials
      • 19.4.16.4. Sales Footprint
      • 19.4.16.5. SWOT Analysis
      • 19.4.16.6. Strategy Overview
        • 19.4.16.6.1. Marketing Strategy
        • 19.4.16.6.2. Product Strategy
        • 19.4.16.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology